Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4.
- DOI
- 10.1124/dmd.121.000508
- Published
- 2021 Sep
- Container
- Drug metabolism and disposition: the biological fate of chemicals
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1124/dmd.121.000508,
title = {Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4.},
author = {Tang LWT and Teng JW and Verma RK and Koh SK and Zhou L and Go ML and Fan H and Chan ECY},
year = {2021},
journal = {Drug metabolism and disposition: the biological fate of chemicals},
doi = {10.1124/dmd.121.000508},
url = {https://doi.org/10.1124/dmd.121.000508}
}RIS
TY - JOUR TI - Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4. AU - Tang LWT AU - Teng JW AU - Verma RK AU - Koh SK AU - Zhou L AU - Go ML AU - Fan H AU - Chan ECY PY - 2021 JO - Drug metabolism and disposition: the biological fate of chemicals DO - 10.1124/dmd.121.000508 UR - https://doi.org/10.1124/dmd.121.000508 ER -
APA
LWT, T., JW, T., RK, V., SK, K., L, Z., ML, G., H, F., & ECY, C. (2021). Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4.. Drug metabolism and disposition: the biological fate of chemicals. https://doi.org/10.1124/dmd.121.000508
Source records
- pubmed · retrieved 2026-09-25T06:34:38.158Z